Anemia: all 1,768 studies
Page 18 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.
- Heart Failure and AnemiaCompletedNCT00049985Phase 2
- Epoetin Beta in Treating Anemia in Patients With Cervical CancerCompletedNCT00046969Phase 4
- A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.CompletedNCT00040677Phase 2
- Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?Status unknownNCT00039884Phase 2
- Anemia in Patients With a Non-Myeloid MalignancyCompletedNCT00038064Phase 3
- Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IICompletedNCT00037388
- Chemotherapy Related AnemiaCompletedNCT00035607Phase 2
- Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00030550Phase 2
- Induction of Stable Chimerism for Sickle Cell AnemiaCompletedNCT00029393Phase 2
- Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaCompletedNCT00029380Phase 2
- Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
- Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionCompletedNCT00023296Phase 1
- Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00022386Phase 4
- Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic AnemiaStatus unknownNCT00017654Not applicable
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
- Thalidomide in Treating Patients With Myelodysplastic SyndromeCompletedNCT00015990Phase 2
- Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
- Stem Cell Mobilization Potential in Patients With Aplastic Anemia in RemissionCompletedNCT00011830Phase 1
- Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan AnemiaCompletedNCT00011505Phase 2
- Oral Manifestations of Aplastic AnemiaCompletedNCT00006300
- BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid LeukemiaCompletedNCT00006213Phase 1
- Stroke Prevention in Sickle Cell Anemia (STOP 2)CompletedNCT00006182Phase 3
- Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's AnemiaStatus unknownNCT00006127Phase 1
- Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial TherapyCompletedNCT00005942Phase 1/2
- Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic AnemiaCompletedNCT00005935Phase 2
- Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's AnemiaCompletedNCT00005898Phase 1/2
- Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's AnemiaStatus unknownNCT00005896Phase 1
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's AnemiaCompletedNCT00005892Not applicable
- Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's AnemiaCompletedNCT00005891Not applicable
- Tipifarnib in Treating Patients With Myelodysplastic SyndromesCompletedNCT00005845Phase 1
- Aplastic Anemia Epidemiology: Incidence and Case-controlCompletedNCT00005682
- Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell CenterCompletedNCT00005327
- Anemia and Surgery: Indications For TransfusionCompletedNCT00005308
- Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study DataCompletedNCT00005307
- Drug Etiology of Aplastic Anemia and Related DyscrasiasCompletedNCT00005302
- PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic SyndromeCompletedNCT00005064Phase 1
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic SyndromeCompletedNCT00004918Phase 1/2
- Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related FatigueCompletedNCT00004914Phase 2
- Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesCompletedNCT00004787Phase 2
- Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell AnemiaCompletedNCT00004492Phase 1/2
- Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic AnemiaCompletedNCT00004474Phase 3
- Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00004464Phase 2
- Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
- Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic AnemiaCompletedNCT00004323Phase 2
- Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003681Phase 2
- Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
- Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
- The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZTCompletedNCT00002302Not applicable
- A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With CytopeniaCompletedNCT00002258Phase 1
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002073Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002072Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002071Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With AnemiaCompletedNCT00002042Not applicable
- Treatment Program for Anemia in AIDS PatientsCompletedNCT00002022Not applicable
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell AnemiaCompletedNCT00001716Phase 2
- Comparing Therapies for the Treatment of Severe Aplastic AnemiaCompletedNCT00001626Phase 2
- Gene Therapy for the Treatment of Fanconi's Anemia Type CCompletedNCT00001399Phase 1
- Stem Cell Factor Medication for Aplastic AnemiaCompletedNCT00001398Phase 1
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)CompletedNCT00000623
- Cord Blood Stem Cell Transplantation Study (COBLT)CompletedNCT00000603Phase 2
- Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)CompletedNCT00000602Phase 2
- Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3
- Stroke Prevention in Sickle Cell Anemia (STOP 1)CompletedNCT00000592Phase 3
- Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus InfectionCompletedNCT00000587Phase 2
- Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)CompletedNCT00000586Phase 3